Clinical Trials
COVID-19
Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against
Shots: The preclinical results have demonstrated that CT-P59 has neutralizing effect against the South African variant and showed a reduction in viral load of SARS-CoV-2 and in binding affinity against […]readmore